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Breast cancer, which continues to rob the world of approximately half a million women per 
year, is surprisingly poorly understood. Despite application of all the tools of epidemiol- 
ogy: ecological studies, migrant studies, case-control and cohort studies, and measurement 
of multiple exposures at various times of life, we still cannot advise women on how to 
protect themselves or their daughters from breast cancer. The disease has a familial and a 
hormonal component, but current knowledge of these components does not adequately 
explain breast-cancer risk. In the search for strategies to prevent this devastating disease, 
potential food-borne exposures have been studied in both animal models and in women. 
These include studies of the relationship of the macronutrients (fat, and alcohol, as well as 
total energy intake), studies of antioxidant micronutrients, studies of body fat and oes- 
trogen levels, and studies of specific foods (such as cruciferous vegetables and soyabean 
products). Even substances carried by food, such as the pesticide dichloro-diphenyltri- 
chlorethane (DDT), have received and continue to receive scrutiny. The present paper will 
attempt to summarize current knowledge and belief in the area of these food-borne ex- 
posures. 
DIETARY FAT, ENERGY INTAKES AND BREAST CANCER 
The involvement of dietary fat as a risk factor for breast cancer remains controversial. 
There seems to be a strong and consistent relationship between per capita average total fat 
disappearance and breast-cancer incidence, when assessed in international ecological 
studies (Prentice & Sheppard, 1989). However, results of case-control and cohort studies 
in which diet was assessed by food-frequency questionnaire are inconsistent. The 
controversy surrounding this has focused in part on colinearity with energy intakes 
(Palmgren, 1993). Particularly after adjustment for energy intakes, the independent effect 
of total dietary fat intakes appears to be minimal if existent at all (Hulka, 1989). 
The importance of fat intake to breast cancer needs to be examined both in its role as a 
contributor of energy, and in its potential for influencing risk independent of an energy 
effect. Non-energy-adjusted models ask whether absolute intakes of fat contribute to breast 
cancer, either through an association with energy intakes or otherwise. Energy-adjusted 
models ask something much more subtle: to what extent does the amount of fat consumed, 
beyond that expected of a woman at her reported energy intake level, relate to breast- 
cancer risk, when fat is exchanged isoenergetically for other nutrients? Some animals, such 
as rats, do appear to adjust their energy intake to the nutrient density of their feed (Braden 
& Carroll, 1986). Hamsters, on the other hand, will substantially increase body weight if 
fed on a fat-rich diet ad libitum (Birt et al. 1989). Human subjects are unfortunately more 
like hamsters: in free-living human populations, as with caged hamsters, dietary fat is 
rarely exchanged isoenergetically for other macronutrients. Instead, people consuming 
more fat tend to consume more total energy and become fatter (Astrup ef al. 1995). 
Therefore, the public health importance of the contribution of fat to total energy intakes 
remains strong, even if the effect is through total energy intake. 
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Energy-adjusted models are justified when biological hypotheses suggest that fat, 
above and beyond its contribution to energy intake, contributes to breast-cancer risk. This 
might be the case if fat carries carcinogens (for example, pesticides) or if certain types of 
fat are particularly biologically active. Examples of the difference in hypotheses are 
expressed in Fig. 1. 
In animal models, total energy .intake remains one of the most important predictors of 
carcinogenesis (Albanes, 1987). In epidemiological studies, which are subject to biased 
reporting of intakes, the association is less consistent (Howe et al. 1990; Hunter et al. 
1996). This may be due to a differential under-reporting of food consumption among more 
obese women (Lichtman et al. 1992), or greater energy intakes among the most-physically- 
active women. 
Pooled analyses of case-control studies from eight countries with approximately 4400 
cases of breast cancer show a 25 % increase in breast-cancer risk associated with a 100 g/d 
increase in fat intake. Since 100 g fat represents 3-8 MJ or approximately 40 % of the total 
energy requirement of a normal woman, changes of this magnitude are unlikely (Howe et 
al. 1990). A pooled analysis of cohort studies of breast cancer from four countries and 
including approximately 4980 cases found a relative risk of a similar magnitude, with an 
increase in risk of 7 % per 25 g fat after deattenuation (Hunter et al. 1996). This increase in 
risk, however, was not statistically significant. For the most part, these cohort studies 
examine post-menopausal diets in relation to post-menopausal breast-cancer risk. None of 
these studies addresses the question as to whether fat-rich diets in childhood and during 
puberty are related to breast-cancer risk in adulthood. 
INDIVIDUAL FATTY ACIDS AND BREAST CANCER 
Epidemiological studies that calculate risk ratios for total fat fail to take into account the 
biological non-equivalence of the various types of fatty acids. Studies of the metabolic 
relationships of fat intake and human blood lipids have shown how important it is to allow 
for the differences in individual fatty acids, since different families and specific fatty acids 
within families have biological effects which differ both in their magnitude and the 
direction of effect on eicosanoid production as well as on carcinogenesis in animal models. 
The confusion and conflicting results regarding fat intake may be due to the physiological 
importance of individual fatty acids which are generally inadequately separated in human 
studies. 
More adipose tissue \ 
\ 
.Earlier menarche, increased oestrogen production 
\ 
increased risk of breast cancer 
Fig. 1. Alternative mechanisms underlying a fat-breast cancer relationship. 
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Few studies have examined the components of fat, individual fatty acids, or classes 
such as short-, medium- and long-chain fatty acids, truns-fatty acids, or various of mono- 
and polyunsaturated fatty acids in relation to breast cancer. This is largely due to the 
difficulty in estimating intakes, which are a function of sources of oils and fats, types of 
fish, and other facets of the diet which are poorly known to the consumer. Dietary 
assessment tends to remain at the level of consumption of types of foods, such as olive oil 
or fish; and not their fatty acid compositions. These foods can carry other substances, such 
as phenols, which may account for any association with risk or any protective effects. 
It is generally difficult to obtain accurate information on dietary intakes in 
epidemiological studies (Barrett-Connor, 1991). Intake of foods, when assessed by 
interview or questionnaire, may be recalled differentially between cases and controls. The 
use of food-composition tables may also introduce errors, because of large variations in 
nutrient content of some foods. Furthermore, when measuring intake, individual variation 
in absorption and metabolism is not taken into account. Intakes of fatty acids pose even 
greater problems than many other nutrients. 
Where available, molecular markers of intake often are preferable. Plasma or serum 
concentrations are used most often (Bates & Thurnham, 1991). Although adipose-tissue 
analysis is a reliable alternative to dietary records and probably superior for the assessment 
of diet in the distant past, few biomarker studies of the profiles of individual fatty acid 
stores in adipose tissue or other media exist to date (Kohlmeier & Kohlmeier, 1995; 
Kohlmeier, 1997). The relative abundance of individual fatty acids in adipose tissue 
reflects the composition of habitual diet. One of the few large studies of breast cancer to 
use biomarkers of adipose tissue as a long-term integrated biomarker of dietary intakes is 
the European Community Multicentre Study on Antioxidants, Myocardial Infarction and 
Cancer of the Breast (EURAMIC) Study. 
EURAMIC STUDY 
Between 1990 and 1992 a multi-national case-control study was conducted in five 
European countries: Northern Ireland, Germany, The Netherlands, Spain and Switzerland. 
The incidence of breast cancer has an approximately twofold range between countries (38- 
72 per 100000) with the lowest risk of disease in Spain. The purpose of this study was to 
examine potential protective roles of antioxidants in the development of breast cancer. A 
common protocol for recruitment, sampling and exposure assessment was developed. The 
participating physicians in this study were trained in the sampling techniques with written 
and videotaped instructions. Technicians were trained in sample handling, and all samples 
were transported to the coordinating centre. Central laboratory analyses were the core of 
this study: the levels of carotenoids, tocopherols and fatty acid composition of the gluteal- 
adipose-tissue samples were determined in the laboratories of the Toxicology and Nutrition 
Institute in Zeist, The Netherlands. 
The specific purpose of the EURAMIC study was to relate the levels of fat-soluble 
antioxidant nutrients and Se in tissues with a low turnover, which provide biomarkers of 
the integrated long-term intake of these nutrients, to risk of breast cancer. The central 
hypothesis was that concentration of a-tocopherol and p-carotene in adipose tissue, and of 
Se in toenails is lower in newly-diagnosed breast cancer cases as compared with healthy 
population controls (Kardinaal et al. 1993). In addition, the study developed a component 
to examine relationships between stores of individual fatty acids and risk of breast cancer. 
700 cases and controls from five diverse European countries were enrolled in this multi- 
centred case-control study. The biomarker-based findings from this study on the 
relationship between dietary factors and breast-cancer risk are presented below. 
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MONOUNSATURATED FATS AND BREAST CANCER 
Most of the studies on monounsaturated fats actually focus on the differences in 
consumption of olive oil between groups of women. A number of epidemiological studies 
of olive oil and breast-cancer risk have pointed to a protective effect among women who 
consume olive oil more frequently. Women consuming olive oil more than once daily have 
breast-cancer risks which are up to one-third lower than that of the non-consumers in Italy, 
Greece and Spain (Martin-Moreno et al. 1994; LaVecchia et al. 1995; Trichopolou et al. 
1995). Olive oil is, however, a complex product containing various levels of 
monounsaturates, and vastly differing amounts of vitamin E, depending on the source 
tree and where it is located. The consumption of olive oil may also be strongly associated 
with socio-economic status, or other dietary characteristics, such as lower usage of butter 
or margarine. In epidemiological studies of diet which calculate all sources of 
monounsaturates, and in biomarker studies, intake of monounsaturates per se is not 
associated with lower breast-cancer risks (Kohlmeier, 1997). 
POLYUNSATURATED FATTY ACIDS 
Animal models of cancer using chemical carcinogens can generally not produce tumours in 
the absence of n-6 fatty acids. This source of essential fatty acids is known to regulate 
synthesis of prostaglandins, which in turn can regulate tumour growth, metastases, and can 
suppress host immune responsiveness (Nogushi et al. 1995). 
n-3 Fatty acids (largely fish oils) are seen, when consumed in high amounts, to be 
inhibitory of tumourigenesis. As with olive oil, consumption of the source food (fish), is 
often taken as a surrogate for n-3 consumption. The problem with this is that, depending on 
the type of fish consumed, and its preparation style, consumption can be poorly, and, in 
some cases, negatively associated with erythrocyte membrane levels of long-chain n-3 fatty 
acid concentrations (Olsen et al. 1995). This may be a function of low intake levels, or the 
contribution of other fats being consumed, for example, with breaded, fried fish products. 
It is becoming increasingly clear that the production of active eicosanoids is regulated 
by the type of precursor fatty acid. Prostaglandins of the 2-series and leukotrienes of the 4- 
series are produced from n-6 fatty acids, whereas the respective 3- and 5-series are 
derivatives of n-3 fatty acids (Fig. 2). The latter are known to reduce chemically-induced 
breast-cancer growth in rats (Nogushi et al. 1995). This may be through inhibition of 
oxidative metabolism of arachidonic acid via the cyclooxygenase pathway of prostaglandin 
synthesis. However, the actual function of individual fatty acid metabolites in women is not 
clear, and the mechanisms by which fatty acids stimulate or inhibit tumours remain 
controversial. 
The rate-limiting enzyme, &6-desaturase, shows a greater affinity for fatty acids of the 
n-3 family. The result of this is production of eicosanoids which are very similar in 
structure, but can be antagonistic to those produced from the n-6 fatty acid family. 
Examples of this are the aggregating and vasocontricting effects of thromboxane A2 from 
the n-6 family, and the anti-aggregating effects of thromboxane A3 from the n-3 family. 
Evidence is accumulating which suggests that more important than the absolute 
amount of a fatty acid is its concentration relative to that of its competitors in 
lipooxygenase (EC 1.13.1 1.12) and cyclooxygenase pathways of eicosanoid production. 
Preliminary results from the EURAMIC study suggest that a higher relative concentration 
of n-3 fatty acids may be protective (Simonsen et al. 1996). 
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Fig. 2. Pathways of n-6 and n-3 essential fatty acid (EFA) metabolism. LT, leukotrienes; F'G, prostaglandin; TX, 
thromboxanes. 
TRANS-FATTY ACIDS AND BREAST CANCER 
Trans-fatty acids are formed largely through the hydrogenation of vegetable oils to 
enhance stability. They are produced enzymically to some degree naturally, but the 
majority of trans-fats in Western populations are consumed in processed foods. These fatty 
acids are known to have the ability to impair microsomal desaturation and elongation of 
essential fatty acids to their long-chain polyunsaturated metabolites. They compete for 
desaturase enzyme sites and potentially reduce production of the 3-series eicosanoids 
(Kinsella et al. 1979; de Schrijver & Privett, 1982; Lawson et al. 1983; Mahfouz et al. 
1984; Koletzko, 1992). Although there has been considerable study of the effects of intakes 
of trans-fatty acids on lipoprotein metabolism and cardiovascular disease, only two studies 
have examined relationships between trans-fatty acid stores and cancer in human subjects. 
In a study of Americans in whom stores of trans-fatty acids are twice as high as those in 
Europe, increases in risk were found at some levels of greater trans-fatty acid intake, 
although without an overall linear trend (London et al. 1993). Within the EURAMIC study 
an increase in risk of breast cancer has been found among those women with greater stores 
of trans-fatty acids (Kohlmeier et al. 1995). 
ANTIOXIDANTS AND BREAST CANCER 
Serious adverse effects arise in the presence of excessive concentrations of oxygen beyond 
the normal need for oxidative processes to support life, or in the absence of adequate 
antioxidant protection. These effects include peroxidation of membrane lipids, the 
hydroxylation of nucleic acid bases and the oxidation of protein moieties. 
Oxidative stress is enhanced by inflammation, exercise, radiation exposure, surgery, air 
pollution, reperfusion, cigarette smoking and dietary intakes of polyunsaturated fatty acids. 
The endogenous sources of oxidants include normal respiration, phagocytosis, cytochrome 
P450 enzymes, and peroxisomes. The degradation of fatty acids by peroxisomes can cause 
the release of peroxide into other cell compartments and result in oxidative DNA damage. 
Fatty acid oxidation can also directly cause oxidative damage through lipid peroxidation, 
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the creation of mutagenic lipid epoxides, lipid hydroperoxides, lipid alkoxyl and peroxyl 
radicals and enals (Ames et at. 1993). As quenchers of free radicals, naturally-occurring 
antioxidants such as carotenoids and tocopherols can theoretically block potential DNA 
damage caused by free radicals. 
A multitude of epidemiological studies have provided evidence that eating behaviour 
patterns consistent with a high fruit and vegetable intake carry lower cancer risks (Block et 
al. 1992). However, the association between intake of fruits and vegetables rich in 
carotenoids, or plasma carotene levels, and a decreased risk of cancer appears to be most 
consistent for lung cancer and stomach cancer (Gey et al. 1987; Wald et at. 1988; Connett 
et al. 1989) and less consistent for cancers of the breast (Wald et al. 1984; Paganini-Hill et 
al. 1987; Rohan et al. 1988; Potischman et al. 1990; Comstock et al. 1991). Since 
carotenoids serve as markers of other dietary factors in the same source foods, which may 
actually be responsible for the protective effects seen for certain dietary patterns, and there 
is little evidence of a specific /?-carotene association, it appears unlikely that any of the 
polyphenols in fruits and vegetables currently under investigation will turn out to be strong 
predictors of breast-cancer risk. 
Attention in epidemiological studies has focused on studying whether /?-carotene 
intakes are protective. At least seven studies have reported on the plasma concentrations of 
/?-carotene as a function of breast-cancer risk (Willett et al. 1984; Knekt, 1988; Marubini et 
al. 1988; Wald et al. 1988; Basu et al. 1989; Potischman et al. 1990; London et al. 1991). 
Lower mean concentrations were found in cases in three of these studies (Gey et al. 1987; 
Basu et al. 1989; Potischman et al. 1990); however, the difference was only significant in 
one of these studies (Potischman et al. 1990). Many of these studies were rather small and 
so lacked the power to detect a difference. In most studies, the diets of the women enrolled 
were quite homogeneous, which might mask a true effect. To assess the public health 
significance of antioxidants, and to provide recommendations on their use as preventives, 
requires epidemiological research on the modulators and effects of these substances. It is 
also vital that studies have adequate power, and are conducted in populations with 
sufficient variance in exposure using objectively-determined exposure levels. The 
EURAMIC study, which addresses a number of the limitations of geographically-insular 
epidemiological studies, also found little evidence of an important role for /?-carotene in 
breast-cancer risk (van’t Veer et al. 1996). 
Analyses from the EURAMIC study revealed two surprises: first, the concentrations of 
/?-carotene in the adipose tissue were lowest among women in the southern-most countries, 
where rates of breast cancer were the lowest. It would have been expected that levels in 
these women would be the highest from their diets, which are richer in fruits and 
vegetables than in the northern countries. Second, no protective effect of high adipose 
stores of either /?-carotene or a-tocopherol, or from a combination of antioxidants, was 
seen. In fact, the direction of the a-tocopherol effect, although not statistically significant, 
was contrary to expectations. 
CRUCIFEROUS VEGETABLES AND BREAST CANCER 
The modulation of carcinogenesis by the consumption of cruciferous vegetables has been 
investigated in laboratory animals that were exposed to known carcinogens. Tumour 
development has often been compared in animals with and without cabbage-supplemented 
diets (Wattenberg, 1983; Birt et al. 1987; Temple & Basu, 1987; Temple & el Khatib, 
1987; Scholar et al. 1989). A number of these studies provide evidence of an effect on the 
production of some tumours. Incidence of mammary tumours, particularly in mice and rats, 
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seemed to be reduced on the addition of 5 2 0 %  of cabbage by weight to the diet 
(Stoewsand et al. 1988; Bresnick et al. 1990). 
The active ingredients in Crucifera have not been definitively determined. Among the 
more than 2000 naturally-occurring compounds in Brassica (Huang & Ferraro, 1992), 
phenolic compounds have drawn attention. The action of some flavonoids is mediated by 
binding to oestrogen receptors which may regulate gene transcription and protect against 
certain cancers (Baker, 1992). Among the phenols, dithiolthiones and the isothiocyanates 
formed on cleavage of glucosinolates are among the strongest inducers of quinone 
reductase (EC 1.6.99.2), an important detoxifying phase-11-enzyme (Prestera et al. 1993). 
Isothiocyanates stimulate acutely the activity of a wide range of phase-XI-enzymes. The 
induction of glutathione-S-transferase (EC 2.5.1.18) and glucuronidase may enhance the 
excretion of carcinogens through the bile and urine. The net effect of this induction may be 
chemoprotective, but that remains to be proven. 1,2-Dithio1-3-thiones, which occur 
naturally in Brassica, are under study in clinical trials as chemoprotective agents (Ansher et 
al. 1986). It should be noted that both pro- and anti-carcinogenic activities have been 
ascribed to indole derivatives and isothiocyanates (McDanell et al. 1989). 
More closely related to breast-cancer risk in particular is the study of the effect of 
indole-3-carbinol on oestrogen metabolism. Indole-3-carbinol has been shown to be anti- 
proliferative in cell systems (Newfield et al. 1993). The balance of c- 16a-hydroxyoestrone 
to C2 hydroxyoestrone, i.e. the ratio, fully-potent : weakly-anti-oestrogenic oestrogens, is 
being studied as a potential mechanism. Feeding of pure indole-3-carbinol reduces the ratio 
16a2-hydroxylation : 2-hydroxylation of oestradiol (Michnovicz & Bradlow, 1991 ; Telang 
et al. 1992). This is the inverse of the effect expected from oestrogenic pesticides, as 
described later (p. 376). 
XENO-OESTROGENS 
Recently, it has been suggested that exposure to environmental oestrogens may be related 
to risk of breast cancer. These xeno-oestrogens have been linked to the hypothesis that 
cumulative exposure to oestrogens plays a role in breast-cancer aetiology. Two of the xeno- 
oestrogens under study involve exposure through the diet: phyto-oestrogens, which are 
naturally-occurring plant compounds, and organochlorine pesticides such as DDT, which 
persist in the environment and may be ingested in foods as well as through the skin and 
respiratory tract. Both groups of compounds have been shown to affect oestrogen 
metabolism in vivo and in vitro. While phyto-oestrogens are believed to reduce the risk of 
breast cancer because of their low potency relative to endogenous oestradiol, 
organochlorine pesticides have been hypothesized to amplify oestrogen activity, increasing 
risk. 
Phyto-oestrogens 
Interest in phyto-oestrogens as potential anti-carcinogens has evolved largely in response 
to the suggestion that high intakes of soyabean foods may contribute to the lower incidence 
of breast cancer in Japan, China, and other countries in Asia. These foods are not a 
traditional part of Western diets. Soyabeans are a rich source of isoflavones, one of two 
classes of phyto-oestrogens which are important in the human diet. Soyabeans have by far 
the highest concentration of isoflavones, which are found mainly in legumes; chick peas 
(Cicer arietinum) are another dietary source. Genistein, the most extensively studied 
isoflavone, is the main isoflavone in soyabeans, accounting for two-thirds of soyabean 
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isoflavone content (Messina et al. 1994). Lignans, another important type of phyto- 
oestrogen, are derived from the metabolism of lignins (found in plant cell walls), and are 
produced from almost all cereals and vegetables. 
Phyto-oestrogens bind to oestrogen receptors, but induce less potent oestrogen activity 
than endogenous oestrogens. Plant oestrogens are believed to reduce risk of breast cancer 
through their net anti-oestrogenic effect. Effects of these compounds on hormone 
metabolism have been shown in both human subjects and animals. Soyabean consumption 
increases menstrual cycle length and decreases circulating levels of oestradiol in human 
subjects (Lu et al. 1996). A 1994 review of epidemiological studies on phyto-oestrogens 
and breast cancer reported that three of four studies on intakes of various soyabean foods 
and breast cancer found statistically significant inverse relationships (Messina et al. 1994). 
One of these found protective associations only in pre-menopausal women. The study 
which found no relationship used fat from soyabean products as the measure of exposure 
(Hirohata et al. 1985). Data from animal and in vitro experiments with mammary cancers 
also suggest that soyabean may be protective (Messina et al. 1994). However, results of 
recent studies on genistein reveal an oestrogen agonistic effect resulting in proliferation of 
oestrogen-dependent human breast-cancer cells and enhanced tumour growth at low 
concentrations (Helferich, 1996). Thus, here too, the story remains unclear regarding a net 
protective effect of consumption of soyabean in breast-cancer incidence or recurrence. 
At this time, associations between breast-cancer risk and consumption of soyabean 
foods are not definitively linked to oestrogen bioavailability. Since soyabean foods contain 
other substances which may be anti-carcinogens, it is possible that non-oestrogenic 
properties of flavonoid-containing foods (e.g. antioxidant or anti-mutagenic properties) 
may contribute to a reduction in cancer risk. Evidence of a protective effect of soyabean 
products on non-hormonal cancers lends support to this alternative hypothesis, and argues 
against an oestrogen-related effect. Associations with soyabean product consumption may 
also be confounded by other dietary patterns or specific food items for which consumption 
is strongly correlated with soyabean intakes. Further study is needed to confirm the 
existence of a protective effect of soyabean and other foods rich in phyto-oestrogens, and 
to determine what properties of soyabean foods may be responsible for any effects. 
Organochlorine pesticides 
Research conducted to date has focused on the pesticide DDT and its metabolite, 1,l- 
dichloro-2,2-bis(p-chlorophenyl) ethylene (DDE). DDT use has been banned for some time 
in most industralized countries, but it continues to be widely-used in many developing 
nations. Although levels are declining in countries where use has been banned, DDT 
remains ubiquitous in the environment due to its long half-life. Because its use has been 
discontinued, current levels of DDT in the food chain in industrialized countries are 
believed to be low. The low level of exposure, and the relatively low potency of 
organochlorine chemicals compared with other oestrogens, has led some researchers to 
argue that these chemicals are unlikely to be important health hazards (Safe, 1995). 
DDT and DDE are fat-soluble and, therefore, accumulate and persist in the 
environment and in human adipose tissue. These compounds are believed to mimic 
oestrogen activity in the body. Unlike phyto-oestrogens, organochlorines are expected to 
increase net exposure to biologically-active oestrogen. In the laboratory, organochlorines 
increase the hydroxylation of oestradiol to 16-a-hydroxyoestrone, a potently active form of 
oestrogen, altering the ratio, 16-a-hydroxyoestrone : 2-hydroxyoestrone, a less-active 
metabolite (Davis & Bradlow, 1995). Elevated levels of the more active form of oestrogen 
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have been found in breast tumours, suggesting a possible causal link (Davis & Bradlow, 
1995). 
Epidemiological studies on DDE and risk of breast cancer have provided equivocal 
results. Positive relationships have been reported in three case-control studies (Falck et al. 
1992; Wolff et al. 1993; Dewailly et al. 1994), but these results have been based on small 
sample sizes (from thirty-five to 229 subjects). Odds ratios reported in these studies ranged 
from 2 to greater than 10. These positive relationships have not been confirmed by three 
larger, more recent studies (300-606 subjects), including two studies which measured DDE 
levels an average of 14 years or more before diagnosis (Krieger et al. 1994; Sutherland et 
al. 1996). In one of these studies (Krieger et al. 1994), however, there were positive 
relationships within individual ethnic group strata. Serum DDE levels were elevated in 
Caucasian and in African-American women with breast cancer relative to controls of the 
same ethnicity, while higher DDE levels appeared protective in Asians (Krieger et al. 
1994). Preliminary results from the EURAMIC study, which measured levels in gluteal 
adipose tissue, also fail to support a causal link (Lobbezoo et al. 1997). 
To date, no strong and consistent effect of pesticide exposure has been identified. Two 
of the three studies which found positive associations between breast cancer and pesticide 
exposure (Wolff et al. 1993; Dewailly et al. 1994) relied on measures of DDE in serum or 
plasma obtained shortly before (6 months) or after diagnosis. In these studies, the possible 
influence of cancer-related changes in metabolism or weight cannot be excluded as reasons 
for the elevated levels in cases. Furthermore, exposures earlier in life may be more relevant 
for risk of breast cancer (Wolff & Toniolo, 1995). The studies which measured blood levels 
prospectively did not confirm positive associations. The two studies using adipose tissue 
levels of DDE also found inconsistent results (Falck et al. 1992; Lobbezoo et al. 1997). 
However, because of the small size of the pilot study, Falck et al. (1992) and others, who 
found elevated DDE in cases relative to controls, were not able to adjust for potential 
confounding factors. 
ALCOHOL 
The epidemiological literature on alcohol consumption and risk of breast cancer generally 
supports a weak causal association (Longnecker, 1994; Hunter & Willett, 1996). Relative 
risks reported in the literature are variable, but on the whole suggest that mean intakes of as 
little as one drink daily may be harmful. In a recent meta-analysis, the odds ratio for one 
drink daily was estimated to be 1-11 (95 % CI 1-07-1-16), and 1-24 (95 % CI 1-15-1.34) for 
two drinks daily, with stronger relationships for increasing levels of consumption 
(Longnecker, 1994). Even a small increase in risk is potentially of public health 
significance, since moderate drinking is a common, modifiable exposure. 
A number of pathways thiough which ethanol, the active constituent of alcoholic 
beverages, may increase risk of breast cancer have been suggested, although at this time the 
mechanisms are not well understood. Ethanol itself is not a carcinogen, but is converted to 
a potentially carcinogenic metabolite (acetaldehyde) in the body. Alcohol has also been 
associated with oxidative stress in the liver, which may induce the activity of other 
enzymes, resulting in increased production of carcinogenic metabolites. Ethanol has also 
been shown to increase the permeability of cells to other potential carcinogens (Thomas, 
1995). Animal studies suggest that ethanol consumption can stimulate cell proliferation in 
mammary tissue, which may increase risk of benign breast disease and cancer. Recently, 
ethanol has been shown to increase circulating plasma oestrone and oestradiol levels in pre- 
menopausal women (Reichman et al. 1993). This suggests that drinking alcohol elevates 
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exposure to bioavailable oestrogens, providing another possible link with the hormonal 
pathways hypothesized to be involved in the aetiology of breast cancer. 
Poor understanding of the mechanisms complicates measurement of the relevant 
dimension of alcohol drinking for breast-cancer research: the timing, amounts and types of 
alcoholic beverages which are relevant for risk of breast cancer are not known. Most 
studies have measured average consumption of ethanol in the recent past, perhaps 5-10 
years before diagnosis. However, adolescent drinking, or drinking during early adulthood, 
may be more important determinants of risk. A few studies (Harvey et al. 1987; van’t Veer 
et al. 1989; Young, 1989; Longnecker et al. 1995a,b) have explored the effects of early 
drinking habits; most of these studies suggest that there may be risk associated with 
drinking before age 30-35 years independent of later drinking. Past drinking was 
associated with increased risk of breast cancer in the EURAMIC study (odds ratio 1-73, 
(95% CI 1-07-2.79); M. A. Royo-Bordonana, J. M. Martin-Moreno, E. Guallar, L. 
Gorgoja, P. van’t Veer, M. Mendez, J. K. Huttunen, B. C. Martin, A. F. M. Kardinaal, J. 
Fernandix-Crehuet, M. Thamm, J. J. Strain, F. J. Kok and L. Kohlmeier, unpublished 
results). Patterns of drinking, bingeing v. regular consumption, may also be important, but 
have not been explored. Types of beverages with different constituents, wine, beer and 
spirits, may also have different effects on breast-cancer risk, although the literature to date 
does not seem to indicate important heterogeneity by type (Longnecker, 1994). 
A few studies have suggested the effect of a threshold at two to three drinks (30g) 
daily (Garfinkel et al. 1988; Toni010 et al. 1989; Howe et al. 1991), but this hypothesis has 
not been consistently supported in the literature. Results from the EURAMIC study, which 
excluded heavy drinkers, may be consistent with a threshold effect. Mean alcohol intakes 
among current drinkers ranged from 3.0 to 14.0 g/d in the EURAMIC population, and there 
was no significant increase in risk of breast cancer associated with current drinking (M. A. 
Royo-Bordonana, J. M. Martin-Moreno, E. Guallar, L. Gorgoja, P. van’t Veer, M. Mendez, 
J. K. Huttunen, B. C. Martin, A. F. M. Kardinaal, J. Fernandix-Crehuet, M. Thamm, J. J. 
Strain, F. J. Kok and L. Kohlmeier, unpublished results). 
SUMMARY AND CONCLUSION 
What we know about prevention of breast cancer is related to lifetime oestrogen exposure 
and exposures to specific oestrogens at vulnerable periods of life. This can be influenced by 
diet. The strongest indicator of a diet-related effect to date is the fairly consistent increase 
in breast cancer among women who are tall or obese (Hunter & Willett, 1993). The other 
dietary factors, summarized in Table 1 are less strongly associated with breast-cancer risk 
in epidemiological studies. 
The relationship between fat and breast-cancer risk has been extensively studied but 
remains somewhat uncertain. Fat, as a contributor to energy intakes and energy imbalance, 
is probably a factor in the higher breast-cancer rates in Western countries. Beyond its role 
as an energy source, the evidence for an independent effect of dietary fat on breast-cancer 
risk is weak. More focused analyses of the role of individual fatty acids, and on lipid- 
related pesticide exposures, may reveal strong effects which are currently masked by the 
use of inadequate exposure measures, as well as by measurement error. 
Currently, there is substantial evidence of a weak relationship with alcohol 
consumption, even at frequencies of drinking of less than once daily. The evidence of a 
protective role for antioxidants is weaker for breast cancer than for other cancers. This 
might by expected in a cancer which is not strongly associated with cigarette smoking. 
Specific foods are being studied for other potentially-active ingredients which may be 
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f, Increased risk J, reduced risk -, no evidence of a relationship. 
involved in hormone metabolism, but conclusive results for soyabean or cruciferous 
vegetables are not yet available. Studying these relationships will continue to be a 
challenge for researchers because of the difficulties in measuring dietary exposures, which 
is complicated by the uncertainty of the relevant time frame for exposure assessment. 
While substantial attention has been focused on studying diet in relation to incidence, 
the potential for diet to reduce recurrence of breast cancer is thoroughly under-studied. 
There is little reason to believe that the factors which influence the incidence of breast 
cancer, perhaps during childhood and puberty, are the same as those which affect 
recurrence in adulthood. In this area, the very limited evidence available suggests that 
study of biologically-active fatty acids is promising. 
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